Where are we going? Where have we been? What is the future? Last month, Tempus purchased Paige AI for $81M, largely in the form of Tempus stock to, as reports mention, for PaigeAI's datasets from 7 million slides, perhaps most of...

By Simon Häger, Product manager Sectra Digital Pathology Many pathology labs are currently switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. This transition is particularly...

Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com.  It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...

Earlier this week, Simon Häger, Product Manager, Sectra Digital Pathology Solution wrote a nice reflection/opinion piece on Sectra's website entitled "Who Can Claim Ownership of a Pathology Image?" Simon reflects on "single vendor" or...

Leica Biosystems and UCLA Department of Pathology and Laboratory Medicine announce a collaboration that will accelerate innovation and the adoption of digital pathology VISTA, CA – May 11, 2016 – Leica Biosystems and UCLA Department of...

The featured post for today is guest written by Dr. Anil Parwani, known throughout the industry as a key opinion leader and has been very active in digital pathology among many other professional and research interests. In his post he looks...